Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : AZD8421
Catalog No.: PC-22118Not For Human Use, Lab Use Only.
AZD8421 (AZD-8421) is a potent, highly selective CDK2 inhibitor with IC50 of 9 nM, >300-fold selectivity over CDK9.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
AZD8421 (AZD-8421) is a potent, highly selective CDK2 inhibitor with IC50 of 9 nM, >300-fold selectivity over CDK9.
AZD8421 forms hydrogen bonding interaction with Lys89 (a CDK2-specific residue) near the solvent region of the ATP-binding pocket.
AZD8421 displays high selectivity over CDK1, CDK4 and CDK6.
AZD8421 potently inhibits cell proliferation (69 nM, OVCAR3), correlated with inhibition of pRB, arrest in G1/S phase of the cell cycle and induction of senescence, in a CCNE1 amplified cell line.
AZD8421 shows combination benefit when combined with approved CDK4/6 inhibitors in CDK4/6 inhibitor resistant breast cancer cell lines.
AZD8421 potently suppresses phosphorylation of Rb, and demonstrates robust monotherapy and CDK4/6i combination activity in breast and ovarian in vivo models.
AZD8421 shows robust monotherapy activity in a CCNE1 amplified ovarian model OVCAR3 with regressions seen with monotherapy and in combination with palbociclib in CDK4/6 inhibitor resistant breast PDXs.
| M.Wt | 440.57 | |
| Formula | C18H32N8O3S | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Christopher R. Denz, et al. Cancer Res (2024) 84 (7_Supplement): ND06.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
